Myxoid\Round Cell Liposarcoma (MRCLS) Revisited: An Analysis of 418 Primarily Managed Cases

Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

(2010) G. Germano et al.   CANCER RESEARCH

Clinicopathologic Prognostic Factors of Pure Myxoid Liposarcoma of the Extremities and Trunk Wall

(2010) Yoshihiro Nishida et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma

(2010) David Roberge et al.   RADIOTHERAPY AND ONCOLOGY

Liposarcomas in Young Patients

(2009) Rita Alaggio et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma

(2009) Peter W. M. Chung et al.   CANCER

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

(2009) George D. Demetri et al.   JOURNAL OF CLINICAL ONCOLOGY

Liposarcoma

(2008) Katarina Engström et al.   CANCER

Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma

(2008) J.-Y. Blay et al.   CLINICAL CANCER RESEARCH

Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis

(2008) Ronald SA de Vreeze et al.   MODERN PATHOLOGY

Excellent Local Control Rates and Distinctive Patterns of Failure in Myxoid Liposarcoma Treated With Conservation Surgery and Radiotherapy

(2007) B. Ashleigh Guadagnolo et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS